These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28273994)

  • 21. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention).
    Taniwaki M; Stefanini GG; Silber S; Richardt G; Vranckx P; Serruys PW; Buszman PE; Kelbaek H; Windecker S;
    J Am Coll Cardiol; 2014 Apr; 63(16):1617-25. PubMed ID: 24530680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.
    Kandzari DE; Rao SV; Moses JW; Dzavik V; Strauss BH; Kutryk MJ; Simonton CA; Garg J; Lokhnygina Y; Mancini GB; Yeoh E; Buller CE;
    JACC Cardiovasc Interv; 2009 Feb; 2(2):97-106. PubMed ID: 19463409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term (> 3 years) clinical and angiographic outcomes of coronary multilink stent implantations: a single center experience.
    Sonmez K; Turan F; Gencbay M; Degertekin M; Duran NE
    Angiology; 2004; 55(5):469-77. PubMed ID: 15378108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.
    Suttorp MJ; Laarman GJ; Rahel BM; Kelder JC; Bosschaert MA; Kiemeneij F; Ten Berg JM; Bal ET; Rensing BJ; Eefting FD; Mast EG
    Circulation; 2006 Aug; 114(9):921-8. PubMed ID: 16908768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of different expansion strategies on coronary stent deployment in a tapered artery.
    Shen X; Ji S; Xie Z; Deng Y
    Technol Health Care; 2017 Jul; 25(S1):21-28. PubMed ID: 28582888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries.
    Ashby DT; Dangas G; Mehran R; Lansky AJ; Narasimaiah R; Iakovou I; Polena S; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB
    Am J Cardiol; 2002 May; 89(10):1162-6. PubMed ID: 12008168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vessel caliber and restenosis: a prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient.
    Ruygrok PN; Webster MW; Ardill JJ; Chan CC; Mak KH; Meredith IT; Stewart JT; Ormiston JA; Price S
    Catheter Cardiovasc Interv; 2003 Jun; 59(2):165-71. PubMed ID: 12772233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal Stent Elongation of a Tapered Lesion during Percutaneous Coronary Intervention: A Case Report.
    Matsumoto S; Sakakibara M; Nishikawa N
    Int J Angiol; 2019 Sep; 28(3):200-201. PubMed ID: 31452588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
    Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S
    J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between diabetic and non-diabetic patients after successful percutaneous coronary intervention for chronic total occlusions in the drug-eluting stent era.
    Ruiz-Garcia J; Teles R; Rumoroso JR; Cyrne Carvalho H; Goicolea FJ; Moreu J; Mauri J; Mainar V; García E; Moreno R;
    Rev Port Cardiol; 2015 Apr; 34(4):263-70. PubMed ID: 25840644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-stage hybrid coronary revascularization with long-term follow-up.
    Adams C; Burns DJ; Chu MW; Jones PM; Shridar K; Teefy P; Kostuk WJ; Dobkowski WB; Romsa J; Kiaii B
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):438-42; discussion 442-3. PubMed ID: 23956269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and long-term outcomes of drug-eluting stent implantations in aorto-ostial, left anterior descending artery-ostial, and nonostial lesions.
    Hsieh IC; Chen CC; Chang SH; Hsieh MJ; Wang CY; Lee CH; Lin FC
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):727-34. PubMed ID: 23592601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery.
    Tsagalou E; Chieffo A; Iakovou I; Ge L; Sangiorgi GM; Corvaja N; Airoldi F; Montorfano M; Michev I; Colombo A
    J Am Coll Cardiol; 2005 May; 45(10):1570-3. PubMed ID: 15893168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT Trial.
    Roguin A; Camenzind E; Kerner A; Beyar R; Boersma E; Mauri L; Steg PG; Wijns W
    JACC Cardiovasc Interv; 2017 Mar; 10(6):548-556. PubMed ID: 28335893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy of sirolimus-eluting stent for small vessel disease--subanalysis of Cypher Stent Japan Post-Marketing Surveillance Registry.
    Fujimoto H; Ikari Y; Nakamura M
    J Cardiol; 2013 Jan; 61(1):31-7. PubMed ID: 23182942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate and long-term results of a modified simultaneous kissing stenting for percutaneous coronary intervention of coronary artery bifurcation lesions.
    Isaaz K; Bayle S; Lamaud M; Robin C; Cerisier A; Mayaud N; Richard L; Sabry MH; Khamis H; Abd-Alaziz A; Da Costa A
    J Invasive Cardiol; 2013 Mar; 25(3):126-31. PubMed ID: 23468441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-year follow-up of sirolimus-eluting stents for the treatment of proximal left anterior descending coronary artery stenosis.
    Valencia J; Berenguer A; Mainar V; Bordes P; Gómez S; Tello A; López-Aranda MA; Caturla J
    J Interv Cardiol; 2006 Apr; 19(2):126-34. PubMed ID: 16650240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of FIREHAWK® abluminal groove filled biodegradable polymer sirolimus-eluting stents for the treatment of long coronary lesions: nine-month angiographic and one-year clinical results from TARGET I trial long cohort.
    Xu B; Gao RL; Zhang RY; Wang HC; Li ZQ; Yang YJ; Ma CS; Han YL; Lansky AJ; Huo Y; Li W; Leon MB
    Chin Med J (Engl); 2013 Mar; 126(6):1026-32. PubMed ID: 23506573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.